arXiv:2607. 22727v1 Announce Type: cross Abstract: Medical image segmentation models often report high benchmark accuracy under ideal imaging conditions, yet their failures under clinical degradation can be quiet: sensor noise, patient motion, low- resolution acquisition, and contrast variability may all alter model behavior without producing an obvious warning.
By Pranav Kaliaperumal, Manisha Kaliaperumal
arXiv:2606. 19300v1 Announce Type: cross Abstract: Glioma segmentation in multiparametric MRI is a critical component of treatment planning.
By Xin Ci Wong, Duygu Sarikaya, Kieran Zucker, Marc De Kamps, Nishant Ravikumar
arXiv:2609.06729v2 Announce Type: replace
Abstract: Accurate 3D brain tumour segmentation from multi-modal Magnetic Resonance Imaging (MRI) is essential for clinical diagnosis and treatment planning....
By Libing Kuang, Soren Salehi, Ziling Wu, Ahmad P. Tafti, Armaghan Moemeni
Medical image segmentation models can achieve strong benchmark performance while remaining sensitive to scanner, protocol, and institutional variation. These context shifts alter image appearance without changing the underlying lesion, allowing models to exploit nuisance cues that Dice and HD95 fail to expose.
arXiv:2512. 14937v2 Announce Type: replace-cross Abstract: Gliomas are the most common malignant brain tumors in adults and are among the most lethal.
By Abhijeet Parida, Daniel Capell\'an-Mart\'in, Zhifan Jiang, Nishad Kulkarni, Krithika Iyer, Austin Tapp, Syed Muhammad Anwar, Mar\'ia J. Ledesma-Carbayo, Marius George Linguraru
The paper introduces RABR-Net, a two‑stage framework that refines biomedical image segmentation boundaries by combining multiple uncertainty measures into a boundary‑aware representation. A gated residual refiner uses this representation to selectively correct uncertain boundary pixels while preserving confident regions, leading to modest but statistically significant improvements in Dice, Boundary Dice, and HD95 metrics on a held‑out test set. Qualitative results show the refiner focuses on uncertain cytoplasm and nucleus boundaries, though calibration does not automatically improve.
By Anima Kujur
arXiv:2607. 22749v1 Announce Type: cross Abstract: Tracking residual tumor after surgery is essential for catching recurrence early, but automating post-operative glioma segmentation remains a difficult task.
By Alexandru Cri\c{s}an, Diana Borza
arXiv:2609.24769v1 Announce Type: new
Abstract: Brain metastases are the most common intracranial malignancy, occurring in roughly 30% of patients with primary solid tumors and carrying a median surv...
By Mahdi Islam, Musarrat Tabassum
arXiv:2510.14383v4 Announce Type: replace
Abstract: Accurate brain tumor segmentation is significant for clinical diagnosis and treatment but remains challenging due to tumor heterogeneity. Mamba-bas...
By Danish Ali, Ajmal Mian, Naveed Akhtar, Ghulam Mubashar Hassan
The study explores how adding anatomical priors and active learning can improve the accuracy of deep learning models for segmenting the Clinical Target Volume (CTV) in gastric cancer radiotherapy. Using 100 retrospective CT scans, an nnU‑Net model trained on 10 expert‑contoured cases was enhanced with voxel‑wise anatomical prior maps and iterative active learning over four rounds. The combined approach raised the mean Dice Similarity Coefficient from 0.84 to 0.87, demonstrating that both techniques individually and together improve segmentation performance and generalizability.
By Phillip Chlap, Mark Lee, Trevor Leong, Matthew Field, Jason Dowling, Hang Min, Julie Chu, Jennifer Tan, Phillip K. Tran, Tomas Kron, Annette Haworth, Martin A. Ebert, Shalini K. Vinod, Lois Holloway
arXiv:2609.39429v1 Announce Type: cross
Abstract: Uncertainty Quantification (UQ) is a key requirement for trustworthy AI in high-stakes medical image analysis. In this work, we evaluate UQ in a mult...
By Gonzalo Esteban Mosquera Rojas, Sebastian R. van der Voort, Carolin M. Pirkl, Sandeep Kaushik, Marion Smits, Stefan Klein
In clinical oncology studies, metastatic cancer is commonly evaluated using "Response Evaluation Criteria in Solid Tumors" (RECIST), in which the diameter of up to five lesions is measured and followed over the course of treatment. However, RECIST shows limited correlation with overall survival.